Veradigm | MDRX - القيمة السوقية





القيمة السوقية تغيير تاريخ
Alcidion AUD 141.01M 6.71M 2025-12
Ambu A/S DKK 14.37B 4.05B 2026-05
Amplifon EUR 2.42B 596.88M 2026-05
Cardinal Health USD 49.72B 894M 2026-03
Centene USD 27.16B 10.99B 2026-05
Charles River Laboratories USD 9.29B 1.44B 2026-05
Cigna USD 70.33B 3.19B 2026-03
Coloplast 124.69B 775.88M 2025-12
CVS Health USD 109.3B 17.26B 2026-05
Diasorin EUR 3.56B 202.53M 2026-05
Elevance Health USD 64.31B 13.6B 2026-03
General Electric Aerospace USD 296.49B 28.42B 2026-03
Gulf Medical Proj AED 1.36B 167.74M 2025-12
Humana USD 20.82B 9.99B 2026-03
IQVIA Holdings USD 31.35B 2.72B 2026-05
Laboratory Of America USD 21.93B 1.13B 2026-03
Maximus USD 4.07B 571M 2026-05
McKesson USD 99.18B 6.81B 2026-05
Med Life RON 4.16B 601.5M 2025-09
Molina Healthcare USD 6.94B 1.98B 2026-03
Omnicell USD 1.52B 515M 2026-03
Oriola-kd EUR 213.12M 0 2025-12
Owens Minor USD 217M 154M 2025-12
Quest Diagnostics USD 21.69B 2.39B 2026-03
Rede D'or Sao Luiz BRL 82.63B 6.58B 2026-05
Siemens Healthineers EUR 37.47B 3.48B 2026-05
Supermax Corporation Bhd MYR 1.09B 375.44M 2025-12
UnitedHealth USD 245.61B 53.42B 2026-03
Veeva Systems USD 33.52B 14.21B 2025-12
Veradigm USD 525M 621M 2026-03